These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31913202)

  • 1. Health-related quality of life in renal stone formers: are we improving?
    Serna J; Talwar R; Ziemba JB
    Curr Opin Urol; 2020 Mar; 30(2):190-195. PubMed ID: 31913202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated Methods of Assessing Quality of Life in Stone Disease.
    Talwar R; Ziemba J
    Curr Urol Rep; 2018 Mar; 19(4):25. PubMed ID: 29508081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life disparities among Hispanic/Latinx patients with nephrolithiasis.
    Flores AR; Abedi G; Girgiss CB; Berger JH; Penniston KL; Li S; Friedlander DF; Bechis SK; Sur RL
    Urolithiasis; 2023 Mar; 51(1):48. PubMed ID: 36920673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes in Nephrolithiasis: Can We Do Better?
    Ellison JS; Williams M; Keeley FX
    J Endourol; 2018 Jan; 32(1):10-20. PubMed ID: 29037089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystine Stone Formers Have Impaired Health-Related Quality of Life Compared with Noncystine Stone Formers: A Case-Referent Study Piloting the Wisconsin Stone Quality of Life Questionnaire Among Patients with Cystine Stones.
    Streeper NM; Wertheim ML; Nakada SY; Penniston KL
    J Endourol; 2017 Apr; 31(S1):S48-S53. PubMed ID: 27717296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life.
    Lim JRZ; Scotland KB; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Bird VG; Andonian S; Bhojani N; Canvasser NE; Harper JD; Penniston KL; Chew BH
    J Endourol; 2020 Nov; 34(11):1203-1208. PubMed ID: 32689819
    [No Abstract]   [Full Text] [Related]  

  • 7. Low Income and Nonwhite Race are Strongly Associated with Worse Quality of Life in Patients with Nephrolithiasis.
    Ahmad TR; Tzou DT; Usawachintachit M; Reliford-Titus S; Wu C; Goodman J; Antonelli JA; Viprakasit DP; Averch TD; Sivalingam S; Chew BH; Bird VG; Pais VM; Streeper NM; Sur RL; Nakada SY; Penniston KL; Chi T
    J Urol; 2019 Jul; 202(1):119-124. PubMed ID: 30865567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of kidney stone disease on quality of life in high-risk stone formers.
    Assad A; Raizenne BL; El Yamani MEM; Saud A; Bechis SK; Sur RL; Nakada SY; Streeper NM; Sivalingam S; Pais VM; Chew BH; Bird VG; Andonian S; Penniston KL; Bhojani N
    BJU Int; 2024 May; 133(5):570-578. PubMed ID: 38332669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an instrument to assess the health related quality of life of kidney stone formers.
    Penniston KL; Nakada SY
    J Urol; 2013 Mar; 189(3):921-30. PubMed ID: 23017521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of dyspnea and quality of life in advanced lung disease.
    Mahler DA; Jones PW
    Clin Chest Med; 1997 Sep; 18(3):457-69. PubMed ID: 9329869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery.
    DeVine J; Norvell DC; Ecker E; Fourney DR; Vaccaro A; Wang J; Andersson G
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S69-74. PubMed ID: 21897347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Evidence of Decreased Disease-Specific Health-Related Quality of Life in Asymptomatic Stone Patients.
    Penniston KL; Sninsky BC; Nakada SY
    J Endourol; 2016 May; 30 Suppl 1():S42-5. PubMed ID: 26864746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Bilateral Stone Disease on Patients' Disease Progression and Health-Related Quality of Life.
    Raizenne BL; Deyirmendjian C; Lafontaine ML; Balde M; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Chew BH; Bird VG; Andonian S; Canvasser NE; Harper JD; Penniston KL; Bhojani N
    J Endourol; 2023 Dec; 37(12):1289-1294. PubMed ID: 37767631
    [No Abstract]   [Full Text] [Related]  

  • 14. How Do Urinary Calculi Influence Health-Related Quality of Life and Patient Treatment Preference: A Systematic Review.
    Raja A; Hekmati Z; Joshi HB
    J Endourol; 2016 Jul; 30(7):727-43. PubMed ID: 27080725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the health-related quality of life of kidney stone patients: initial results from the Wisconsin Stone Quality of Life Machine-Learning Algorithm (WISQOL-MLA).
    Nguyen DD; Luo JW; Lu XH; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Chew BH; Bird VG; Andonian S; Canvasser NE; Harper JD; Penniston KL; Bhojani N
    BJU Int; 2021 Jul; 128(1):88-94. PubMed ID: 33205549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of Health-Related Quality of Life Outcomes in Pediatric Neurosurgery: Literature Review.
    Desai VR; Gadgil N; Saad S; Raskin JS; Lam SK
    World Neurosurg; 2019 Feb; 122():252-265. PubMed ID: 30399472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire.
    Penniston KL; Antonelli JA; Viprakasit DP; Averch TD; Sivalingam S; Sur RL; Pais VM; Chew BH; Bird VG; Nakada SY
    J Urol; 2017 May; 197(5):1280-1288. PubMed ID: 27889419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Duration of Stone Disease and the Impact of a Stone Event on Patients' Quality of Life.
    Raizenne BL; Deyirmendjian C; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Chew BH; Bird VG; Andonian S; Canvasser NE; Harper JD; Penniston KL; Bhojani N
    J Endourol; 2022 Oct; 36(10):1371-1376. PubMed ID: 35722905
    [No Abstract]   [Full Text] [Related]  

  • 19. Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire.
    Wu AW; Fink NE; Cagney KA; Bass EB; Rubin HR; Meyer KB; Sadler JH; Powe NR
    Am J Kidney Dis; 2001 Jan; 37(1):11-21. PubMed ID: 11136162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Intervention in Monogenic Stone Formers.
    Policastro LJ; Saggi SJ; Goldfarb DS; Weiss JP
    J Urol; 2018 Mar; 199(3):623-632. PubMed ID: 29061541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.